Initial validation of a self-report measure of the extent of and reasons for medication nonadherence.
about
Self-report measures of medication adherence behavior: recommendations on optimal useCharacterizing weekly self-reported antihypertensive medication nonadherence across repeated occasions.A single-item self-report medication adherence question predicts hospitalisation and death in patients with heart failureUnderstanding disparities in lipid management among patients with type 2 diabetes: gender differences in medication nonadherence after treatment intensificationUnderstanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns FrameworkExtent and reasons for nonadherence to antihypertensive, cholesterol, and diabetes medications: the association with depressive symptom burden in a sample of American veterans.Effectiveness and feasibility of a software tool to help patients communicate with doctors about problems they face with their medication regimen (EMPATHy): study protocol for a randomized controlled trial.Validity of Self-Reported Drug Use Information Among Pregnant Women.Determining the effects and challenges of incorporating genetic testing into primary care management of hypertensive patients with African ancestryThe agreement of patient-reported versus observed medication adherence in type 2 diabetes mellitus (T2DM)Adherence and health care costs.The psychosocial context impacts medication adherence after acute coronary syndrome.Intentional and unintentional non-adherence to medications following an acute coronary syndrome: a longitudinal study.Patient engagement and study design of PROP UP: A multi-site patient-centered prospective observational study of patients undergoing hepatitis C treatment.Evaluation of the Measurement Properties of Self-reported Medication Adherence Instruments Among People at Risk for Metabolic Syndrome: A Systematic Review.Medication Adherence in Patients with Bipolar Disorder: A Comprehensive Review.A theoretical model of how neighborhood factors contribute to medication nonadherence among disadvantaged chronically ill adults.Psychometric Properties of the Four-Item Morisky Green Levine Medication Adherence Scale among Atherosclerosis Risk in Communities (ARIC) Study Participants.Developing a common framework for evaluating the implementation of genomic medicine interventions in clinical care: the IGNITE Network's Common Measures Working Group.Bridging Income Generation with Group Integrated Care for cardiovascular risk reduction: Rationale and design of the BIGPIC study.Costs and beliefs: understanding individual- and neighborhood-level correlates of medication nonadherence among Mexican Americans with type 2 diabetes.Evaluating the Validity and Reliability of the Beliefs About Medicines Questionnaire in Low-Income, Spanish-Speaking Patients With Diabetes in the United States.Jump starting shared medical appointments for diabetes with weight management: Rationale and design of a randomized controlled trial.Development and Initial Validation of the Caregiver Perceptions About Communication With Clinical Team Members (CAPACITY) Measure.Lacunae in noncommunicable disease control program: Need to focus on adherence issues!Informing women with breast cancer about endocrine therapy: effects on knowledge and adherence.Chronic disease management perspectives of colorectal cancer survivors using the Veterans Affairs healthcare system: a qualitative analysis.Developing and validating a theoretical measure of modifiable influences on hormonal therapy medication taking behaviour in women with breast cancer.
P2860
Q26775742-DA5383D9-E3D0-46B2-85D3-5E9488E00BBEQ33604932-A74C3325-3A0A-47B1-B765-FC3D31177E98Q33784870-6E468313-57F3-4CFB-A17C-3685B9BA61C1Q34765398-AE2129DD-FFE3-4453-A659-9BDCA6BCC49DQ35061087-7EB2ECC9-DA21-4405-ABEE-F28AFDFBAEC3Q35136139-02C7E0C3-081E-41CE-8248-50C20ADE74E9Q35538074-6879306B-9AE1-41E2-877C-75FEE35C92C4Q36463778-0EFFB6F6-ACCD-41A4-AE64-25C5CA2D6C2CQ36757756-A3DC708D-F15B-447A-A8F8-F2F82D142915Q37063490-4A9FC049-72A1-4D0C-8067-CB92C8F56AA7Q37603117-B9F05AD1-EB2C-49A0-BA15-0526C10D99EDQ37666296-A56EDC11-41DC-4739-83FB-15C7064DB0C0Q37733137-C161986C-48C3-4AE0-A2FB-201D0283FA3EQ38876302-EFFA77C4-DE7D-4403-9891-2FC4E1C47B90Q38879787-2F710D71-B2B7-432A-88C3-2EF51D20A965Q38902384-EB84B72E-D5F2-4D1B-ACD4-60265360A687Q38994115-3E3C46C8-7B84-4DF8-86A9-2CF404FFC12DQ39092792-A51D2B42-AA02-4E06-8FB1-0B56AE4254CDQ40039177-3BA3D6EF-DED7-4120-93C2-AF0F4A873172Q40174262-CA199241-2F4B-4C10-AAA6-ABE0533FA23EQ44682500-178F729D-C0B1-4B01-B08C-2400388B20CAQ46113002-C3A49324-7206-452C-B04B-EA7B07FCBDB4Q47217762-4D61AC87-EFF3-45CD-AD40-8C52E86876B5Q47673127-4D9902DD-7CF0-4A0A-A1A0-A7A9D9EDD82CQ49855321-3B6EAD22-134B-4379-B2BF-042E86260F65Q50653806-B627E611-7A6E-4045-9DA1-134599C4AEA3Q51742090-C126CCA8-1EB4-48F3-B2F2-7C1A95CC20E4Q52893755-4322791E-F5E4-47CA-B3EB-71F6290B1174
P2860
Initial validation of a self-report measure of the extent of and reasons for medication nonadherence.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Initial validation of a self-r ...... s for medication nonadherence.
@ast
Initial validation of a self-r ...... s for medication nonadherence.
@en
type
label
Initial validation of a self-r ...... s for medication nonadherence.
@ast
Initial validation of a self-r ...... s for medication nonadherence.
@en
prefLabel
Initial validation of a self-r ...... s for medication nonadherence.
@ast
Initial validation of a self-r ...... s for medication nonadherence.
@en
P2093
P2860
P1433
P1476
Initial validation of a self-r ...... ns for medication nonadherence
@en
P2093
Bryce B Reeve
Christopher L Bryson
Matthew L Maciejewski
Patrick Gallagher
Rick H Hoyle
William S Yancy
P2860
P304
P356
10.1097/MLR.0B013E318269E121
P577
2012-12-01T00:00:00Z